Nabriva Therapeutics (NBRVF) Financial Statements

Nabriva Therapeutics's market cap is currently $323.00. The company's EPS TTM is $; its P/E ratio is ―; Nabriva Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.